jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Sept. 07, 2020

Oct. 12, 2023

jRCT1052200052

Japanese HIS-bundle pacing for patient with indication of Cardiac Resynchronization Therapy Trial

J-HIS-CRT

Aug. 17, 2024

7

Seven patients were enrolled in the study and one withdrew consent. Age was 67.7 +-16.3 (mean +-standard deviation) in the CRT group and 66.3 +-8.8 in the His group, and the proportion of women was 33.3% in the CRT group and 0.0% in the His group, with no significant differences between the two groups.

The enrolment period was 2.5 years until 31 March 2023, but the study was discontinued due to poor progress.

Adverse events No adverse events occurred.

No analysis was conducted due to the discontinuation of the study.

No analysis was conducted due to the discontinuation of the study.

Aug. 31, 2023

No

No

https://jrct.mhlw.go.jp/latest-detail/jRCT1052200052

Kusano Kengo

National Cerebral and Cardiovascular Center Hospital

6-1 Kishibe Shimmachi, Suita, Osaka, Japan

+81-6-6170-1070

kusanokengo@ncvc.go.jp

Yurugi Maki

National Cerebral and Cardiovascular Center Hospital

6-1 Kishibe Shimmachi, Suita, Osaka, Japan

+81-6-6170-1070

yurugi.maki@ncvc.go.jp

Complete

Sept. 07, 2020

Mar. 05, 2021
50

Interventional

randomized controlled trial

open(masking not used)

active control

parallel assignment

treatment purpose

1. Subject is 20 years of age or older at the time of consent acquisition
2. Subject who meets CRT indications according to the guidelines of the Japanese Circulation Society
3. Subject planning to implant CRT
4. Subject has signed and dated the informed consent form

1. Subject with a history of CRT implantation
2. Subject with severe heart failure that requires continuous administration of cardiotonic
3. Subject with unstable angina, acute myocardial infarction within 40 days, or within 3 months after coronary artery invasive treatment
4. Subject scheduled for tricuspid valve surgery
5. Pregnant woman
6. Subject participating in other clinical trials or intervention trials
7. Subject judged to be inappropriate to this study for other reasons by the investigator

20age old over
No limit

Both

Heart Failure

His-bundle pacing

Heart Failure

Responder rate 6 months after implantation

1. Amount of change in cardiac function by myocardial scintigraphy at 6 months after implantation (left ventricular ejection fraction: LVEF, left ventricular end systolic volume: LVESV, etc.)
2. Prognosis at 6 and 24 months after implantation (survival rate and cardiovascular event non-incidence rate)
3. Amount of change in NYHA at 6 and 24 months after implantation
4. Amount of change in serum natriuretic peptide levels at 6 and 24 months after implantation

Intramural Research Fund (30-3-1)for Cardiovascular Diseases of National Cerebral and Cardiovascular Center Prospective Intervention Study Using the Existing Devices to Develop a New Therapeutic Guideline
Not applicable
Osaka Metropolitan University Hospital Certified Review Board
6th floor of Abeno Medix,1-2-7 Asahicho,Abeno-ku,Osaka, Osaka

+81-6-6645-3456

irb@med.osaka-cu.ac.jp
Approval

Aug. 21, 2020

none

History of Changes

No Publication date
10 Oct. 12, 2023 (this page) Changes
9 April. 11, 2023 Detail Changes
8 Dec. 14, 2022 Detail Changes
7 Sept. 23, 2022 Detail Changes
6 Dec. 09, 2021 Detail Changes
5 Aug. 30, 2021 Detail Changes
4 Mar. 10, 2021 Detail Changes
3 Feb. 12, 2021 Detail Changes
2 Jan. 29, 2021 Detail Changes
1 Sept. 07, 2020 Detail